Recent car-t Articles
Despite the remarkable progress in drug development across several populations of cancer, troubling facts have recently emerged about several expensive FDA-approved anticancer drugs.
We are hearing a lot about cancer immunotherapy these days. Modern approaches and technology are now helping to revolutionize cancer care. What decision-making power do we hold to influence an immune-therapeutic response to help avoid, manage, or treat a cancer diagnosis? And how might this affect long-term survival?